COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 80 clinical trials
AGILE (Early Phase Platform Trial for COVID-19)

The AGILE platform master protocol allows incorporation of a range of identified and yet-to-be-identified candidates as potential treatments for adults with COVID-19 into the trial. Candidates

  • 31 May, 2021
  • 4 locations
Evaluate the Safety Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

The SARS-CoV-2 virus is responsible for the COVID-19 pandemic. The pandemic emerged from Wuhan Province in China in December 2019 and was declared by the WHO Director-General a Public Health

  • 03 May, 2021
  • 8 locations
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers

This is an First In Human (FIH), observer-blinded, randomized, placebo-controlled, parallel group study to evaluate the safety and immunogenicity of KBP-COVID-19 plus CPG adjuvant vaccine in

  • 19 Jun, 2021
  • 9 locations
COVID-19 Study of Safety and Tolerability of Alvelestat

) orally twice per day for 10 days added to standard of care in adult patients (18 years) with COVID-19 respiratory disease.

  • 09 May, 2021
  • 1 location
An Open Study on the Safety Tolerability and Immunogenicity of "Sputnik Light" Vaccine

Phase I-II open prospective, two-stage, non-randomized study in healthy volunteers.

  • 01 Feb, 2021
  • 1 location
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)

This clinical trial will evaluate the safety, tolerability and immunogenicity of GLS-5310 DNA vaccine against SARS-CoV-2(COVID-19) in healthy volunteers.

  • 27 Jan, 2021
  • 1 location
Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

COVID-19 at Northwestern Memorial Hospital. The patients will be randomized in a 1:1 ratio to receive standard of care plus TM5614 or standard of care plus placebo.

  • 03 Feb, 2021
  • 1 location
Safety Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

Phase I/II study to determine safety, tolerance and immunogenicity of EuCorVac-19, a recombinant protein vaccine, for the prevention of COVID-19 in healthy adults

  • 08 May, 2021
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

functioning. Once compromised by inflammation, the immune system loses its capacity to recognize antigens and dependably defend the body against disease and illness. When COVID-19 invades humans, it

  • 04 Jun, 2021
  • 1 location
Safety and Immunogenicity Study of GX-19N a COVID-19 Preventive DNA Vaccine in Healthy Adults

The objective of our study is to evaluate safety, tolerability, and immunogenicity of COVID-19 preventive DNA vaccine in healthy volunteers.

  • 29 Jan, 2021
  • 5 locations